Tabacon, Ruliet .

HRN: 21-85-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2026
CEFUROXIME 1.5GM (VIAL)
01/23/2026
01/24/2026
IV
1.5g
PTOR
G5P4(4014) AUB Probably Endometrial Pathology
Remove - Pending Acceptance
01/24/2026
CEFUROXIME 500MG (TAB)
01/24/2026
01/31/2026
PO
500 Mg
BID
S/P D&C
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: